METROMILE INC (MILE) Stock Fundamental Analysis

NASDAQ:MILE • US5916971071

1.05 USD
+0.07 (+7.67%)
At close: Jul 27, 2022
1.02 USD
-0.03 (-2.86%)
After Hours: 7/27/2022, 8:12:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

MILE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 149 industry peers in the Insurance industry. MILE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MILE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MILE had negative earnings in the past year.
MILE Yearly Net Income VS EBIT VS OCF VS FCFMILE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -50M -100M -150M -200M

1.2 Ratios

Industry RankSector Rank
ROA -49.8%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MILE Yearly ROA, ROE, ROICMILE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 -20 -40 -60 -80 -100

1.3 Margins

  • MILE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) -135.85%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MILE Yearly Profit, Operating, Gross MarginsMILE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • MILE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MILE has more shares outstanding than it did 1 year ago.
  • MILE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MILE Yearly Shares OutstandingMILE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 20M 40M 60M 80M 100M
MILE Yearly Total Debt VS Total AssetsMILE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

  • MILE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.55%
MILE Yearly LT Debt VS Equity VS FCFMILE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M -100M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MILE Yearly Current Assets VS Current LiabilitesMILE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 100K 200K 300K 400K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for MILE have decreased strongly by -9949.68% in the last year.
EPS 1Y (TTM)-9949.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.81%

3.2 Future

  • Based on estimates for the next years, MILE will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.03% on average per year.
  • Based on estimates for the next years, MILE will show a very strong growth in Revenue. The Revenue will grow by 29.64% on average per year.
EPS Next Y62.43%
EPS Next 2Y32.18%
EPS Next 3Y18.29%
EPS Next 5Y11.03%
Revenue Next Year21.19%
Revenue Next 2Y30.12%
Revenue Next 3Y29.37%
Revenue Next 5Y29.64%

3.3 Evolution

MILE Yearly Revenue VS EstimatesMILE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 50M 100M 150M 200M
MILE Yearly EPS VS EstimatesMILE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • MILE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MILE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MILE Price Earnings VS Forward Price EarningsMILE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.35
MILE Per share dataMILE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • MILE's earnings are expected to grow with 18.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.18%
EPS Next 3Y18.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MILE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

METROMILE INC

NASDAQ:MILE (7/27/2022, 8:12:46 PM)

After market: 1.02 -0.03 (-2.86%)

1.05

+0.07 (+7.67%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-10
Earnings (Next)08-08
Inst Owners0%
Inst Owner Change0%
Ins Owners4.44%
Ins Owner Change0%
Market Cap136.94M
Revenue(TTM)108.32M
Net Income(TTM)-147.15M
Analysts45.71
Price Target4.08 (288.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB N/A
EV/EBITDA -0.35
EPS(TTM)-1.14
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.83
BVpS1.21
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -49.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -135.85%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9949.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.29%
EPS Next Y62.43%
EPS Next 2Y32.18%
EPS Next 3Y18.29%
EPS Next 5Y11.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.81%
Revenue Next Year21.19%
Revenue Next 2Y30.12%
Revenue Next 3Y29.37%
Revenue Next 5Y29.64%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

METROMILE INC / MILE FAQ

What is the fundamental rating for MILE stock?

ChartMill assigns a fundamental rating of 3 / 10 to MILE.


Can you provide the valuation status for METROMILE INC?

ChartMill assigns a valuation rating of 2 / 10 to METROMILE INC (MILE). This can be considered as Overvalued.


Can you provide the profitability details for METROMILE INC?

METROMILE INC (MILE) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for MILE stock?

The Earnings per Share (EPS) of METROMILE INC (MILE) is expected to grow by 62.43% in the next year.